NIKA
NIKA PHARMACEUTICALS INC.
Price Chart
Latest Quote
$0.51
+0.00 (+0.00%)
Current Price
| Previous Close | $0.51 |
| Open | $0.20 |
| Day High | $0.20 |
| Day Low | $0.20 |
| Volume | 100 |
Stock Information
| Shares Outstanding | 1.05B |
| Total Debt | $332K |
| Cash Equivalents | $2K |
| Net Income | $-77K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $534.55M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $534.88M |
| Income | $-77K |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.01 |
| Current Ratio | 0.06 |
Returns & Margins
| ROA | -172.62% |
Ownership
| Insider Ownership | 86.28% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.31 |
| SMA50 | $0.44 |
| SMA200 | $0.46 |
| RSI | 100.00 |
| ATR | 0.0441 |
| Shares Float | 275.78M |
| Volatility | -0.53 |
| Rel Volume | 2.82 |
Performance History
| Week | +152.38% |
| Month | -0.04% |
| Quarter | -32.52% |
| 6 Months | +82.07% |
| YTD | +34.12% |
| Year | -26.12% |
| 10 Years | -96.36% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-19 | $0.51 | 100 |
| 2026-06-18 | $0.51 | 0 |
| 2026-06-17 | $0.51 | 0 |
| 2026-06-16 | $0.51 | 0 |
| 2026-06-15 | $0.51 | 249 |
| 2026-06-12 | $0.20 | 0 |
| 2026-06-11 | $0.20 | 0 |
| 2026-06-10 | $0.20 | 0 |
| 2026-06-09 | $0.20 | 0 |
| 2026-06-08 | $0.20 | 0 |
| 2026-06-05 | $0.20 | 0 |
| 2026-06-04 | $0.20 | 0 |
| 2026-06-03 | $0.20 | 159 |
| 2026-06-02 | $0.20 | 0 |
| 2026-06-01 | $0.20 | 0 |
| 2026-05-29 | $0.20 | 0 |
| 2026-05-28 | $0.20 | 0 |
| 2026-05-27 | $0.20 | 200 |
| 2026-05-26 | $0.51 | 0 |
| 2026-05-22 | $0.51 | 0 |
| 2026-05-21 | $0.51 | 0 |
| 2026-05-20 | $0.51 | 0 |
| 2026-05-19 | $0.51 | 0 |
About NIKA PHARMACEUTICALS INC.
Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
đ° Latest News
No news articles available at the moment. Check back later for updates on NIKA.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $95,792 | $64,833 | $3,183,715 | $14,712 |
| Operating Expense | $95,792 | $64,833 | $3,183,715 | $14,712 |
| General And Administrative Expense | $95,792 | $64,833 | $183,715 | $14,712 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Normalized Income | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Net Income From Continuing And Discontinued Operation | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Total Operating Income As Reported | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Net Income Common Stockholders | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Net Income | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Net Income Including Noncontrolling Interests | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Net Income Continuous Operations | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Pretax Income | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Operating Income | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Per Share | ||||
| Diluted EPS | $0.00 | $-0.00 | $-0.00 | $-0.00 |
| Basic EPS | $0.00 | $-0.00 | $-0.00 | $-0.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| EBITDA (Bullshit earnings) | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| EBIT | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Diluted Average Shares | $1,021,674,500 | $876,090,000 | $876,090,000 | $876,090,000 |
| Basic Average Shares | $1,021,674,500 | $876,090,000 | $876,090,000 | $876,090,000 |
| Diluted NI Availto Com Stockholders | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Selling General And Administration | $95,792 | $64,833 | $183,715 | $14,712 |
| Other Gand A | $95,792 | $64,833 | $183,715 | $14,712 |
| Research And Development | - | $0 | $3,000,000 | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-221,230 | $-82,149 | $-17,316 | $-23,619 |
| Total Assets | $17,934 | $19,596 | $864 | $399 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $17,934 | $19,596 | $864 | $399 |
| Prepaid Assets | $15,851 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $2,083 | $19,596 | $864 | $399 |
| Cash And Cash Equivalents | $2,083 | $19,596 | $864 | $399 |
| Cash Financial | $2,083 | $19,596 | $864 | $399 |
| Debt | ||||
| Net Debt | - | - | - | $23,619 |
| Total Debt | - | - | - | $24,018 |
| Long Term Debt And Capital Lease Obligation | - | - | - | $13,500 |
| Long Term Debt | - | - | - | $13,500 |
| Current Debt And Capital Lease Obligation | - | - | - | $10,518 |
| Current Debt | - | - | - | $10,518 |
| Other Current Borrowings | - | - | - | $10,518 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $239,164 | $101,745 | $18,180 | $24,018 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $13,500 |
| Current Liabilities | $239,164 | $101,745 | $18,180 | $10,518 |
| Payables And Accrued Expenses | $239,164 | $101,745 | $18,180 | $10,518 |
| Payables | $239,164 | $101,745 | $18,180 | $10,518 |
| Tradeand Other Payables Non Current | - | - | $0 | $0 |
| Equity | ||||
| Common Stock Equity | $-222,730 | $-83,149 | $-18,316 | $-23,619 |
| Preferred Stock Equity | $1,500 | $1,000 | $1,000 | - |
| Total Equity Gross Minority Interest | $-221,230 | $-82,149 | $-17,316 | $-23,619 |
| Stockholders Equity | $-221,230 | $-82,149 | $-17,316 | $-23,619 |
| Retained Earnings | $-8,927,612 | $-3,400,247 | $-3,335,414 | $-151,699 |
| Other | ||||
| Ordinary Shares Number | $1,018,519,500 | $876,090,000 | $876,090,000 | $876,090,000 |
| Share Issued | $1,018,519,500 | $876,090,000 | $876,090,000 | $876,090,000 |
| Tangible Book Value | $-222,730 | $-83,149 | $-18,316 | $-23,619 |
| Invested Capital | $-222,730 | $-83,149 | $-18,316 | $-23,619 |
| Working Capital | $-221,230 | $-82,149 | $-17,316 | $-10,119 |
| Total Capitalization | $-221,230 | $-82,149 | $-17,316 | $-23,619 |
| Additional Paid In Capital | $8,602,714 | $3,229,489 | $3,229,489 | $88,471 |
| Capital Stock | $103,668 | $88,609 | $88,609 | $39,609 |
| Common Stock | $102,168 | $87,609 | $87,609 | $39,609 |
| Preferred Stock | $1,500 | $1,000 | $1,000 | $0 |
| Dueto Related Parties Current | $239,164 | $101,745 | $18,180 | $10,518 |
| Dueto Related Parties Non Current | - | - | $0 | $13,500 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-139,081 | $-64,833 | $-33,715 | $-14,712 |
| Operating Activities | ||||
| Operating Cash Flow | $-139,081 | $-64,833 | $-33,715 | $-14,712 |
| Cash Flow From Continuing Operating Activities | $-139,081 | $-64,833 | $-33,715 | $-14,712 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | ||||
| Financing Cash Flow | $137,419 | $83,565 | $34,180 | $13,500 |
| Cash Flow From Continuing Financing Activities | $137,419 | $83,565 | $34,180 | $13,500 |
| Issuance Of Capital Stock | - | $0 | $10,000 | $0 |
| Net Common Stock Issuance | - | $0 | $10,000 | $0 |
| Common Stock Issuance | - | $0 | $10,000 | $0 |
| Other | ||||
| Issuance Of Debt | $137,419 | $83,565 | $24,180 | $13,500 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,083 | $19,596 | $864 | $399 |
| Beginning Cash Position | $19,596 | $864 | $399 | $1,611 |
| Changes In Cash | $-17,513 | $18,732 | $465 | $-1,212 |
| Net Issuance Payments Of Debt | $137,419 | $83,565 | $24,180 | $13,500 |
| Net Short Term Debt Issuance | $137,419 | $83,565 | $24,180 | $13,500 |
| Short Term Debt Issuance | $137,419 | $83,565 | $24,180 | $13,500 |
| Other Non Cash Items | $-43,289 | - | $3,150,000 | - |
| Net Income From Continuing Operations | $-95,792 | $-64,833 | $-3,183,715 | $-14,712 |
| Net Long Term Debt Issuance | - | - | $24,180 | $13,500 |
| Long Term Debt Issuance | - | - | $24,180 | $13,500 |
| Change In Working Capital | - | - | - | $0 |
Fetched: 2026-02-02